Europe Stem Cell Therapy Market - Industry Trends and Forecast to 2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	159 Pages	Data Bridge Market Research	May, 2022	DAABD17330410

Best Price Guarantee
Price	from $3,500
Length	159 Pages
Publisher	Data Bridge Market Research
Published Date	May, 2022
SKU	DAABD17330410

Europe Stem Cell Therapy Market - Industry Trends and Forecast to 2029

The Europe stem cell therapy market is projected to register a substantial CAGR of 10.0% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2020, and the forecast period is 2022 to 2029

Market Segmentation:
Europe Stem Cell Therapy Market, Product Type (Bone Marrow Derived Mesenchymal Cells, Placental or Umbilical Stem Cell, Adipose Tissue Derived Mesenchymal Stem Cells, and Others), Type (Allogenic Stem Cell Therapy and Autologous Stem Cell Therapy), Application (Musculoskeletal Disorders, Acute Graft-Versus-Host Disease (AGVHD), Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, and Others), End User (Hospitals and Surgical Centers, Therapeutic Companies, Services Companies, and Others), Distribution Channel (Direct Tender, Third Party Distributors), Country (Italy, Belgium, Czech Republic, Germany, U.K., Spain, Hungary, and Poland) Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the Europe stem cell therapy market are:
• The rise in good manufacturing practice certifications for the setup of stem cell manufacturing facilities in Europe
• Rise in healthcare infrastructure in Europe

Market Players

Some of the major players operating in the Europe stem cell therapy market are:
• Takeda Pharmaceutical Company Limited
• Holostem Terapie Avanzate S.r.l.
• JCR Pharmaceuticals Co., Ltd
• ANTEROGEN.CO., LTD
• MEDIPOST
• Orthofix Medical Inc.
• BioRestorative Therapies, Inc.
• STEMPEUTICS RESEARCH PVT LTD
• Pluristem Inc.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Europe Stem Cell Therapy Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Europe Stem Cell Therapy Market: Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Product Segment Lifeline Curve; 2.8 Dbmr Market Position Grid; 2.9 Vendor Share Analysis; 2.10 Market End User Coverage Grid; 2.11 Secondary Sources
3 Executive Summary
4 Premium Insights: 4.1 Pestel; 4.2 Porter's Five Forces Model
5 Epidemiology
6 Pipeline Analysis For The Europe Stem Cell Therapy Market
7 Europe Stem Cell Therapy Market: Regulations
8 Market Overview: 8.1 Drivers; 8.1.1 The Rise In Prevalence And Incidence Of Chronic Diseases; 8.1.2 Rise In Investment In Research And Development And Availability Of Funding For Stem Cell Research; 8.1.3 Growing Biotechnology Sector; 8.1.4 Rise In Gmp Certification Approvals For Cell Therapy Production Facilities; 8.1.5 Rise In Clinical Trials For Stem-cell-based Therapies; 8.2 Restraints; 8.2.1 The Rise In Cost Of Stem-cell-based Therapy Research; 8.2.2 The Risks Faced While Undergoing Stem Cell Therapy; 8.2.3 Ethical Concerns Related To Stem Cell Therapy Research; 8.2.4 Availability Of Alternatives; 8.3 Opportunities; 8.3.1 Strategic Initiative By Market Players; 8.3.2 Rise In Healthcare Expenditure; 8.3.3 The Emergence Of Induced Pluripotent Stem Cells (Ipscs); 8.4 Challenges; 8.4.1 The Lack Of Skilled Professionals Required For Stem Cell Therapy; 8.4.2 Stringent Regulations
9 Europe Stem Cell Therapy Market, By Product Type: 9.1 Overview; 9.2 Bone Marrow Derived Mesenchymal Stem Cells; 9.3 Placental/Umbilical Stem Cell; 9.4 Adipose Tissue Derived Mesenchymal Stem Cells; 9.5 Others
10 Europe Stem Cell Therapy Market, By Type: 10.1 Overview; 10.2 Allogeneic Stem Cell Therapy; 10.2.1 Musculoskeletal Disorders; 10.2.2 Wounds And Injuries; 10.2.3 Acute Graft-versus-host Disease (Agvhd); 10.2.4 Surgeries; 10.2.5 Gastrointestinal Diseases; 10.2.6 Other Application; 10.3 Autologous Stem Cell Therapy; 10.3.1 Cardiovascular Diseases; 10.3.2 Gastrointestinal Diseases; 10.3.3 Other Application
11 Europe Stem Cell Therapy Market, By Application: 11.1 Overview; 11.2 Musculoskeletal Disorders; 11.3 Wounds And Injuries; 11.4 Acute Graft-versus-host Disease (Agvhd); 11.5 Surgeries; 11.6 Gastrointestinal Diseases; 11.7 Cardiovascular Diseases; 11.8 Other Application
12 Europe Stem Cell Therapy Market, By End User: 12.1 Overview; 12.2 Hospital And Surgical Centers; 12.3 Therapeutic Companies; 12.4 Services Companies; 12.5 Others
13 Europe Stem Cell Therapy Market, By Distribution Channel: 13.1 Overview; 13.2 Direct Tender; 13.3 Third Party Distributors
14 Europe Stem Cell Therapy Market, By Region: 14.1 Europe; 14.1.1 Italy; 14.1.2 Belgium; 14.1.3 Czech Republic; 14.1.4 Germany; 14.1.5 U.K.; 14.1.6 Spain; 14.1.7 Hungary; 14.1.8 Poland
15 Europe Stem Cell Therapy Market: Company Landscape: 15.1 Company Share Analysis: Europe
16 Swot Analysis
17 Company Profile: 17.1 Osiris Therapeutics, Inc. (A Subsidiary Of Smith+Nephew) (2021); 17.1.1 Company Snapshot; 17.1.2 Revenue Analysis; 17.1.3 Company Share Analysis; 17.1.4 Product Portfolio; 17.1.5 Recent Development; 17.2 Jcr Pharmaceuticals Co., Ltd ( (2021); 17.2.1 Company Snapshot; 17.2.2 Revenue Analysis; 17.2.3 Company Share Analysis; 17.2.4 Product Portfolio; 17.2.5 Recent Developments; 17.3 Orthofix Medical Inc. (2021); 17.3.1 Company Snapshot; 17.3.2 Revenue Analysis; 17.3.3 Company Share Analysis; 17.3.4 Product Portfolio; 17.3.5 Recent Developments; 17.4 Medipost (2021); 17.4.1 Company Snapshot; 17.4.2 Revenue Analysis; 17.4.3 Company Share Analysis; 17.4.4 Product Portfolio; 17.4.5 Recent Developments; 17.5 Takeda Pharmaceutical Company Limited (2021); 17.5.1 Company Snapshot; 17.5.2 Revenue Analysis; 17.5.3 Company Share Analysis; 17.5.4 Product Portfolio; 17.5.5 Recent Development; 17.6 Corestem, Inc. (2021); 17.6.1 Company Snapshot; 17.6.2 Revenue Analysis; 17.6.3 Product Portfolio; 17.6.4 Recent Development; 17.7 Pharmicell Co., Ltd. (2021); 17.7.1 Company Snapshot; 17.7.2 Product Portfolio; 17.7.3 Recent Developments; 17.8 Anterogen.Co., Ltd (2021); 17.8.1 Company Snapshot; 17.8.2 Product Portfolio; 17.8.3 Recent Developments; 17.9 Athersys, Inc.(2021); 17.9.1 Company Snapshot; 17.9.2 Revenue Analysis; 17.9.3 Product Portfolio; 17.9.4 Recent Developments; 17.10 Brainstorm Cell Limited (2021); 17.10.1 Company Snapshot; 17.10.2 Product Portfolio; 17.10.3 Recent Developments; 17.11 Biorestorative Therapies, Inc. (2021); 17.11.1 Company Snapshot; 17.11.2 Revenue Analysis; 17.11.3 Product Portfolio; 17.11.4 Recent Developments; 17.12 Holostem Terapie Avanzate S.R.L. (2021); 17.12.1 Company Snapshot; 17.12.2 Product Portfolio; 17.12.3 Recent Developments; 17.13 International Stemcell Corporation (2021); 17.13.1 Company Snapshot; 17.13.2 Revenue Analysis; 17.13.3 Product Portfolio; 17.13.4 Recent Development; 17.14 Mesoblast Ltd (2021); 17.14.1 Company Snapshot; 17.14.2 Revenue Analysis; 17.14.3 Product Portfolio; 17.14.4 Recent Developments; 17.15 Pluristem Inc.(2021); 17.15.1 Company Snapshot; 17.15.2 Revenue Analysis; 17.15.3 Product Portfolio; 17.15.4 Recent Development; 17.16 Stempeutics Research Pvt Ltd; 17.16.1 Company Snapshot; 17.16.2 Product Portfolio; 17.16.3 Recent Developments; 17.17 U.S. Stem Cell, Inc. (2021); 17.17.1 Company Snapshot; 17.17.2 Revenue Analysis; 17.17.3 Product Portfolio; 17.17.4 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables: Table 1 Europe Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 2 Europe Bone Marrow Derived Mesenchymal Stem Cells In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 3 Europe Placental/Umbilical Stem Cell In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 4 Europe Adipose Tissue Derived Mesenchymal Stem Cells In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 5 Europe Others In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 6 Europe Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 7 Europe Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 8 Europe Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 9 Europe Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 10 Europe Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 11 Europe Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 12 Europe Musculoskeletal Disorders In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 13 Europe Wounds And Injuries In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 14 Europe Acute Graft-versus-host Disease (Agvhd) In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 15 Europe Surgeries In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 16 Europe Gastrointestinal Diseases In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 17 Europe Cardiovascular Diseases In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 18 Europe Other Application In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 19 Europe Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 20 Europe Hospital And Surgical Centers In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 21 Europe Therapeutic Companies In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 22 Europe Services Companies In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 23 Europe Others In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 24 Europe Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million); Table 25 Europe Direct Tender In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 26 Europe Third Party Distributors In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 27 Europe Stem Cell Therapy Market, By Country, 2020-2029 (Usd Million); Table 28 Europe Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 29 Europe Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 30 Europe Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 31 Europe Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 32 Europe Stem Cell Therapy Market, By Applications, 2020-2029 (Usd Million); Table 33 Europe Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 34 Europe Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million); Table 35 Italy Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 36 Italy Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 37 Italy Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 38 Italy Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 39 Italy Stem Cell Therapy Market, By Applications, 2020-2029 (Usd Million); Table 40 Italy Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 41 Italy Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million); Table 42 Belgium Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 43 Belgium Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 44 Belgium Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 45 Belgium Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 46 Belgium Stem Cell Therapy Market, By Applications, 2020-2029 (Usd Million); Table 47 Belgium Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 48 Belgium Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million); Table 49 Czech Republic Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 50 Czech Republic Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 51 Czech Republic Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 52 Czech Republic Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 53 Czech Republic Stem Cell Therapy Market, By Applications, 2020-2029 (Usd Million); Table 54 Czech Republic Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 55 Czech Republic Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million); Table 56 Germany Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 57 Germany Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 58 Germany Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 59 Germany Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 60 Germany Stem Cell Therapy Market, By Applications, 2020-2029 (Usd Million); Table 61 Germany Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 62 Germany Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million); Table 63 U.K. Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 64 U.K. Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 65 U.K. Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 66 U.K. Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 67 U.K. Stem Cell Therapy Market, By Applications, 2020-2029 (Usd Million); Table 68 U.K. Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 69 U.K. Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million); Table 70 Spain Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 71 Spain Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 72 Spain Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 73 Spain Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 74 Spain Stem Cell Therapy Market, By Applications, 2020-2029 (Usd Million); Table 75 Spain Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 76 Spain Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million); Table 77 Hungary Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 78 Hungary Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 79 Hungary Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 80 Hungary Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 81 Hungary Stem Cell Therapy Market, By Applications, 2020-2029 (Usd Million); Table 82 Hungary Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 83 Hungary Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million); Table 84 Poland Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 85 Poland Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 86 Poland Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 87 Poland Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 88 Poland Stem Cell Therapy Market, By Applications, 2020-2029 (Usd Million); Table 89 Poland Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 90 Poland Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million)
List Of Figures: Figure 1 Europe Stem Cell Therapy Market : Segmentation; Figure 2 Europe Stem Cell Therapy Market: Data Triangulation; Figure 3 Europe Stem Cell Therapy Market: Droc Analysis; Figure 4 Europe Stem Cell Therapy Market: Europe Vs Regional Market Analysis; Figure 5 Europe Stem Cell Therapy Market: Company Research Analysis; Figure 6 Europe Stem Cell Therapy Market: Interview Demographics; Figure 7 Europe Stem Cell Therapy Market: Dbmr Position Grid; Figure 8 Europe Stem Cell Therapy Market: Vendor Share Analysis; Figure 9 Europe Stem Cell Therapy Market: End User Coverage Grid; Figure 10 Europe Stem Cell Therapy Market: Segmentation; Figure 11 North America Is Anticipated To Dominate The Europe Stem Cell Therapy Market And Asia-pacific Is Estimated To Be Growing With The Highest Cagr In The Forecast Period Of 2022 To 2029; Figure 12 Increased Incidence Of Chronic Diseases, Rise In Clinical Trials, Gmp Certification And Product Appprovals Is Expected To Drive The Europe Stem Cell Therapy Market From 2022 To 2029; Figure 13 Product Type Segment Is Expected To Have The Largest Share Of The Europe Stem Cell Therapy Market From 2022 & 2029; Figure 14 Drivers, Restraints, Opportunities, And Challenges Of The Europe Stem Cell Therapy Market; Figure 15 Number And Ages Of People 65 Or Older With Alzheimer's Dementia In 2022; Figure 16 Incidence Of Various Types Of Cancer In 2020; Figure 17 Europe Stem Cell Therapy Market: By Product Type, 2021; Figure 18 Europe Stem Cell Therapy Market: By Product Type, 2022-2029 (Usd Million); Figure 19 Europe Stem Cell Therapy Market: By Product Type, Cagr (2022-2029); Figure 20 Europe Stem Cell Therapy Market: By Product Type, Lifeline Curve; Figure 21 Europe Stem Cell Therapy Market: By Type, 2021; Figure 22 Europe Stem Cell Therapy Market: By Type, 2022-2029 (Usd Million); Figure 23 Europe Stem Cell Therapy Market: By Type, Cagr (2022-2029); Figure 24 Europe Stem Cell Therapy Market: By Type, Lifeline Curve; Figure 25 Europe Stem Cell Therapy Market: By Application, 2021; Figure 26 Europe Stem Cell Therapy Market: By Application, 2022-2029 (Usd Million); Figure 27 Europe Stem Cell Therapy Market: By Application, Cagr (2022-2029); Figure 28 Europe Stem Cell Therapy Market: By Application, Lifeline Curve; Figure 29 Europe Stem Cell Therapy Market: By End User, 2021; Figure 30 Europe Stem Cell Therapy Market: By End User, 2022-2029 (Usd Million); Figure 31 Europe Stem Cell Therapy Market: By End User, Cagr (2022-2029); Figure 32 Europe Stem Cell Therapy Market: By End User, Lifeline Curve; Figure 33 Europe Stem Cell Therapy Market: By Distribution Channel, 2021; Figure 34 Europe Stem Cell Therapy Market: By Distribution Channel, 2022-2029 (Usd Million); Figure 35 Europe Stem Cell Therapy Market: By Distribution Channel, Cagr (2022-2029); Figure 36 Europe Stem Cell Therapy Market: By Distribution Channel, Lifeline Curve; Figure 37 Europe Stem Cell Therapy Market: Snapshot (2021); Figure 38 Europe Stem Cell Therapy Market: By Country (2021); Figure 39 Europe Stem Cell Therapy Market: By Country (2022 & 2029); Figure 40 Europe Stem Cell Therapy Market: By Country (2021 & 2029); Figure 41 Europe Stem Cell Therapy Market: By Product Type (2022 & 2029); Figure 42 Europe Stem Cell Therapy Market: Company Share 2021 (%)